Codification of Medicare Drug Price Negotiation: What the Final Rule Means for Manufacturers November 12, 2026
Oncology’s 2027 Access Challenge: Why Provider Economics May Matter as Much as Payer Coverage October 12, 2026
Understanding the Medicare Part D Redesign Impact on Pharma: A Strategic Modeling Approach August 15, 2025
The Price of Progress: Unpacking the Trump Administration’s Drug Pricing Executive Order May 22, 2025
Through a glass darkly: The what, how, and what now for global net price transparency February 13, 2025